Russia says it has detained a suspect in the shooting of a senior military intelligence general in Moscow and accuses Ukraine of involvement, a claim Kyiv has not confirmed.
Eritrea has denied Ethiopia’s claim that its troops crossed the border, calling the report fabricated as the two neighbors trade accusations amid lingering tensions.
A Panama-flagged container ship sank off Phuket after taking on water; all 16 Bangladeshi crew were safely rescued, and authorities responded to drifting containers and an oil slick.
Benjamin Netanyahu meets Donald Trump in Washington to discuss Iran, as diplomatic talks continue and longstanding concerns over nuclear and regional influence remain unresolved.
American Olympians at the Milan-Cortina Winter Games have spoken thoughtfully about U.S. policies and values, blending athletic focus with personal reflections on national issues.
Thirteen people died in Italy’s mountains over one winter week, including ten in avalanches, highlighting the contrast between unstable backcountry slopes and controlled Olympic venues.
Experts warn that Gaza’s post-ceasefire calm may conceal a quiet reconfiguration of territory, aid, and authority with long-term consequences for civilian life.
Patrick Horgan reflects on head contact in hurling, urging careful consideration of player safety amid discussions following comments by Cork manager Ben O’Connor.
Peter Thiel’s hedge fund now holds only three AI-related stocks — Microsoft, Apple, and Tesla — after exiting Nvidia and Palantir, reflecting a measured approach to AI investment.
Bank of France Governor François Villeroy de Galhau will step down in June 2026, over a year before his term ends, to lead a charitable foundation, allowing a successor to be appointed before France’s 2027 election.
Melinda French Gates is directing substantial new funding toward underfunded programs for women and girls, supporting nonprofits, research, and collaborative grant initiatives to redress long‑standing funding gaps.
UK Prime Minister Keir Starmer faces political pressure from revelations about an Epstein-linked appointment but refuses to resign, urging focus on his government’s mission.
American Airlines flight attendants’ union passed a unanimous no‑confidence vote in CEO Robert Isom, citing poor performance, operational issues, and leadership concerns; pilots have also raised similar issues.
Exceptional floods in northern Morocco have displaced over 150,000 people; many wait in temporary shelters with no clear timeline for return.
A landmark trial opened in Santa Fe as New Mexico accuses Meta of failing to protect children from sexual exploitation on its platforms; Meta denies wrongdoing.
The CFPB declined to cooperate with a GAO investigation into its layoffs and operational changes, citing ongoing litigation, and the GAO released a timeline-based report without full agency input.
Family calls for release of unpublished report into a prison death at Cloverhill, seeking clarity and transparency years after the loss.
Kroger has appointed former Walmart U.S. leader Greg Foran as its new CEO, succeeding interim leadership amid competitive retail pressures and strategic transitions.
Novo Nordisk has sued Hims & Hers over alleged patent infringement related to compounded semaglutide obesity drugs, seeking a ban on sales and damages amid broader regulatory scrutiny.
The U.S. and Canada retail operator of Eddie Bauer stores has filed for Chapter 11 bankruptcy amid declining sales and industry challenges, while separate e‑commerce and international operations remain unaffected.
AI‑themed ads at the Super Bowl drew attention but fell short of the emotional resonance achieved by humor and nostalgic storytelling in traditional commercials.
Alphabet is raising substantial funds through global bond issuances to support record capital spending, particularly on artificial intelligence infrastructure and data centers.
Irishman with valid US work permit held by Immigration and Customs Enforcement since September despite no criminal record, green card application pending.
The FDA declined to approve Regenxbio’s gene therapy for Hunter syndrome, citing trial design and surrogate endpoint concerns; the company plans further discussion and data submission.